Optic Neuropathy, Ischemic [clinicaltrials_resource:51c6bb236f530cf456f7e4afda9bcd95]
Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases [clinicaltrials:NCT00404729]clinicaltrials:NCT00759174clinicaltrials:NCT01607671Retrobulbar Triamcinolone Acetonide Injection in the Treatment of NA-AION [clinicaltrials:NCT02329288]
condition [clinicaltrials_vocabulary:condition]
Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup) [clinicaltrials:NCT00000126]Ischemic Optic Neuropathy Decompression Trial (IONDT) [clinicaltrials:NCT00000127]Vision Restoration Therapy (VRT) to Treat Non-Arteritic Anterior Ischemic Optic Neuropathy [clinicaltrials:NCT00140491]Neurotomy of Optic Nerve in Non-Arthritic Anterior Ischemic Optic Neuropathy [clinicaltrials:NCT00372021]Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases [clinicaltrials:NCT00404729]Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy [clinicaltrials:NCT00432393]Intraocular Pressure During Abdominal Aortic Aneurysm (AAA) Repair [clinicaltrials:NCT00450294]clinicaltrials:NCT00561834clinicaltrials:NCT00759174Transcorneal Electrical Stimulation Therapy for Retinal Disease [clinicaltrials:NCT00804102]Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy [clinicaltrials:NCT00813059]clinicaltrials:NCT00867815Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients [clinicaltrials:NCT01064505]A Study to Determine if There is a Possible Association Between Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) and Phosphodiesterase Type 5 (PDE5) Inhibitors [clinicaltrials:NCT01131104]clinicaltrials:NCT01260324Comparison of Intravitreal Bevacizumab and Triamcinolone With Placebo [clinicaltrials:NCT01330524]NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement [clinicaltrials:NCT01411657]clinicaltrials:NCT01607671Assessment of Visual Field-related Endpoints in Patients With Non-arteritic Ischemic Optic Neuropathy [clinicaltrials:NCT01614158]clinicaltrials:NCT01768260clinicaltrials:NCT01975324clinicaltrials:NCT02019927Safety and Efficacy Study of RPh201 Treatment of Ischemic Optic Neuropathy (ION). [clinicaltrials:NCT02045212]Retrobulbar Triamcinolone Acetonide Injection in the Treatment of NA-AION [clinicaltrials:NCT02329288]Phase II/III, Randomized, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Non Arteritic Anterior Ischemic Optic Neuropathy (NAION) [clinicaltrials:NCT02341560]clinicaltrials:NCT02377271Outcomes of Steroid and Oxygen Therapy Versus Placebo Therapy in Non-arteritic Anterior Ischemic Optic Neuropathy [clinicaltrials:NCT02439866]
condition browse [clinicaltrials_vocabulary:condition-browse]
Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup) [clinicaltrials:NCT00000126]Ischemic Optic Neuropathy Decompression Trial (IONDT) [clinicaltrials:NCT00000127]Vision Restoration Therapy (VRT) to Treat Non-Arteritic Anterior Ischemic Optic Neuropathy [clinicaltrials:NCT00140491]Neurotomy of Optic Nerve in Non-Arthritic Anterior Ischemic Optic Neuropathy [clinicaltrials:NCT00372021]Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases [clinicaltrials:NCT00404729]Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy [clinicaltrials:NCT00432393]Intraocular Pressure During Abdominal Aortic Aneurysm (AAA) Repair [clinicaltrials:NCT00450294]clinicaltrials:NCT00561834clinicaltrials:NCT00759174Transcorneal Electrical Stimulation Therapy for Retinal Disease [clinicaltrials:NCT00804102]Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy [clinicaltrials:NCT00813059]clinicaltrials:NCT00867815Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients [clinicaltrials:NCT01064505]A Study to Determine if There is a Possible Association Between Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) and Phosphodiesterase Type 5 (PDE5) Inhibitors [clinicaltrials:NCT01131104]clinicaltrials:NCT01260324Comparison of Intravitreal Bevacizumab and Triamcinolone With Placebo [clinicaltrials:NCT01330524]NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement [clinicaltrials:NCT01411657]clinicaltrials:NCT01607671Assessment of Visual Field-related Endpoints in Patients With Non-arteritic Ischemic Optic Neuropathy [clinicaltrials:NCT01614158]clinicaltrials:NCT01768260clinicaltrials:NCT01975324clinicaltrials:NCT02019927Safety and Efficacy Study of RPh201 Treatment of Ischemic Optic Neuropathy (ION). [clinicaltrials:NCT02045212]Retrobulbar Triamcinolone Acetonide Injection in the Treatment of NA-AION [clinicaltrials:NCT02329288]Phase II/III, Randomized, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Non Arteritic Anterior Ischemic Optic Neuropathy (NAION) [clinicaltrials:NCT02341560]clinicaltrials:NCT02377271Outcomes of Steroid and Oxygen Therapy Versus Placebo Therapy in Non-arteritic Anterior Ischemic Optic Neuropathy [clinicaltrials:NCT02439866]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Optic Neuropathy, Ischemic [clinicaltrials_resource:51c6bb236f530cf456f7e4afda9bcd95]
Bio2RDF identifier
51c6bb236f530cf456f7e4afda9bcd95
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:51c6bb236f530cf456f7e4afda9bcd95
identifier
clinicaltrials_resource:51c6bb236f530cf456f7e4afda9bcd95
title
Optic Neuropathy, Ischemic
@en
type
label
Optic Neuropathy, Ischemic [clinicaltrials_resource:51c6bb236f530cf456f7e4afda9bcd95]
@en
Optic Neuropathy, Ischemic